RxDoctor Payments Data

Justin Slavin, MD

Neurological Surgery · Worcester, MANPI 1790944668

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.4% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,289 and has fallen 64.8% since, to $453 in 2025.

$4,803in general payments, 2019–2025

Across 85 payments — averaging $56.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Globus Medical$805
  • Providence Medical Technology, Inc.$624
  • Medtronic$466
  • Spineology Inc.$227
  • Johnson & Johnson$207
  • plus $1K from 25 others
$17,096in research payments, 2019–2025

Across 1 payment — averaging $17,096 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spineology Inc.$17K

What the payments were for

  • Travel & lodging$3648%
  • Food & beverage$4,44092%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,803 in reported general payments places this provider in the 55th percentile of 183 neurological surgery providers in Massachusetts.

See all neurological surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$174,567
Medicare patients
147
Services billed
513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin23$259
Methylprednisolone25$230
Cyclobenzaprine Hcl23$203

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Worcester

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →